Kazia Therapeutics Ltd ADR (KZIA) — Capital Reinvestment Ratio

Latest as of September 2021: 0.50x

Kazia Therapeutics Ltd ADR (KZIA) has a Capital Reinvestment Ratio of 0.50x as of September 2021, meaning it reinvests 1% of its operating cash flow ($3.16 Million) in capital expenditures ($1.58 Million). See Kazia Therapeutics Ltd ADR net asset quality index to measure how much of total assets are equity-financed.

Capital Reinvestment Ratio

0.50x

Capex / Operating Cash Flow

Operating Cash Flow

$3.16 Million

USD

Capital Expenditures

$1.58 Million

USD

Data as of

Sep 2021

Most recent filing

Annual Capital Reinvestment Ratio for Kazia Therapeutics Ltd ADR (None–None)

Year-by-year Capital Reinvestment Ratio for Kazia Therapeutics Ltd ADR from None to None. For live market cap and broader valuation context, see market value of Kazia Therapeutics Ltd ADR.

Year	Reinvestment Ratio	Operating CF (USD)	Capital Expenditures	YoY Change

Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow